On the other hand, the only other gene that was somehow discriminating between AML subgroups, CD88, was underexpressed in AML2 compared to APL in the RNA-Seq dataset but overexpressed relative to both APL and AML1 in the microarray dataset. This evidence concerns the gene RUNX1 and acute myeloid leukemia.